What is Opus Genetics's cash ratio?

Opus Genetics (IRD) reported cash ratio of 6.4× in Q1 2026.

How has Opus Genetics's cash ratio changed year-over-year?

Opus Genetics's cash ratio increased by 272.5% year-over-year, from 1.7× to 6.4×.

What is the long-term trend for Opus Genetics's cash ratio?

Over 5 years (2020 to 2025), Opus Genetics's cash ratio has grown at a 2.4% compound annual growth rate (CAGR), from 5.1× to 5.8×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

Opus Genetics IRD Cash ratio

Cash ratio at other companies

AbbVieABBV

0.2×+0.1×

MeiraGTx Holdings plcMGTX

0.4×-0.9×

4D Molecular TherapeuticsFDMT

1.7×-3.3×

Opko HealthOPK

0.2×-0.3×

Kodiak Sciences IncKOD

3.4×-1.1×

Regeneron PharmaceuticalsREGN

0.6×-0.3×

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Calculated from Opus Genetics’s reported figures.

cash and equivalents/total current liabilities=6.4×

Based on the most recent quarter.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's cash ratio?: Opus Genetics (IRD) reported cash ratio of 6.4× in Q1 2026.
How has Opus Genetics's cash ratio changed year-over-year?: Opus Genetics's cash ratio increased by 272.5% year-over-year, from 1.7× to 6.4×.
What is the long-term trend for Opus Genetics's cash ratio?: Over 5 years (2020 to 2025), Opus Genetics's cash ratio has grown at a 2.4% compound annual growth rate (CAGR), from 5.1× to 5.8×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.